More on DWTX

- Summary
- Chart
- Profile
- Historical

Data

- Earnings (-133.7% Growth)
- Ratings (10.0 Score)

Upcoming Events

- Earnings (8/19/26)

News

- Analyst Ratings
- Earnings Related
- Guidance
- Insider Trades
- Mgmt Changes
- M & A
- Retail Sales
- Rumors
- Stock Buybacks
More...

Dogwood Therapeutics (NQ:DWTX)
Delayed: 1.57 --0 (-0%)
Prev. Close $1.57  
Open$1.57 
52 Wk High$ 
52 Wk Low$ 
Day High$1.57 
Day Low$1.57 
P/E N/A  
EPS$ 
Volume35 

Friends, Peers and Foes (?): VIRI LSI (more...)

May 18, 2026 08:45 AM Dogwood Therapeutics begins 12-week extension study for pain drug
May 18, 2026 08:45 AM Dogwood Therapeutics Announces Commencement of Halneuron® Chemotherapy Induced Neuropathic Pain Phase 2b Long Term Extension Study
May 15, 2026 11:13 AM Form SCHEDULE 13G Dogwood Therapeutics, Filed by: ARMISTICE CAPITAL, LLC
May 15, 2026 09:21 AM Form 10-Q Dogwood Therapeutics, For: Mar 31
May 14, 2026 08:50 AM Form 8-K Dogwood Therapeutics, For: May 14
May 14, 2026 08:30 AM Dogwood Therapeutics Announces First Quarter 2026 Financial Results
May 7, 2026 08:30 AM Dogwood Therapeutics to Report First Quarter 2026 Financial Results on Thursday, May 14, 2026
Apr 27, 2026 04:27 PM Form ARS Dogwood Therapeutics, For: Dec 31
Apr 27, 2026 02:30 PM Form DEF 14A Dogwood Therapeutics, For: Jun 16
Apr 23, 2026 09:00 AM Dogwood Therapeutics partners with PRIDCor for antiviral assets deal
View All Articles

Entities mentioned with DWTX

View All Entities